Donepezil causes acute increases in regional cerebral blood flow in normal rat

Abstract

associated to aging and AD. (Kalpouzos 2009, Mosconi, 2007). We focused on the small primate (Microcebus murinus (M.m.), during aging some animals develop cognitive impairments (Picq, 2007), amyloid plaque depositions, and altered Tau protein accumulation associated with cerebral atrophy (Kraska, 2009). Brain atrophy is predictive of cognitive alterations (Picq, 2010). The aim of the current study was to evaluate age-associated evolution of glucose uptake in M.m. by using non-invasive FDG PET. Methods: SeventeenM.m. (1.5 to 9 years) were evaluated by PET with MicroPET Focus220 system (FDG: 900mCurie/100g, i.v.) and 3D-MR images were recorded (PharmaScan Bruker 7T). M.m were anesthetized by isoflurane duringimages acquisition. MR and PET images were co-registered by rigid transformations to define volumes of interest (VOI) in brain and appraise Standard UptakeValues (SUV) as well as relative values as compared to whole brain. Results: MR images didn’t reveal any severe atrophy this study is focused on normal aging. PET study revealed a relationship between age and SUVs in the frontal cortex, the cerebellum, and in the whole brain. However, relative values were not correlated with age. The cohort was split by theM.m.midlife (4.5 years) in two groups, young (1.960.2 years) and old animals (6.460.5 years).This second analyse showed a difference between young and old animals in thewhole brain, frontal cortex and cerebellum (t-test).Conclusions:Anage-associated evolution of glucose uptake as measured by SUVs could bedetected in non-severely atrophied M.m. and resembles evolution of the regionalcerebral metabolic rates for glucose (rCMRGlc) observed in healthy aged humans.This study is a first step toward the characterization of age-associated changesof brain glucose uptake inM.m. and will be useful to understand brain aging inM.m.